EVERSANA EVERSANA — Syringe Importer Profile
Pharmaceutical Importer · #11 buyer for Syringe · $589.0K import value · 13 shipments · UNITED STATES · DGFT Verified
EVERSANA EVERSANA is the #11 importer of Syringe from India with $589.0K in import value and 13 verified shipments. EVERSANA EVERSANA holds a 0.4% market share in Syringe imports based in UNITED STATES. The company sources from 1 verified supplier across 8 formulations shipped to 1 country. Overall, EVERSANA EVERSANA imports 5 pharmaceutical products worth $5.6M across 4 therapeutic categories.
EVERSANA EVERSANA — Syringe Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Syringe to EVERSANA EVERSANA?
Verified from 13 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| GLAND PHARMA LIMITED | $589.0K | 13 | 100.0% |
EVERSANA EVERSANA sources Syringe from 1 verified Indian supplier based on 13 customs records. The primary supplier is GLAND PHARMA LIMITED accounting for 100.0% of imports.
How Does EVERSANA EVERSANA Compare to Nearest Syringe Importers?
Buyers ranked immediately above and below #11 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | DUC MINH MEDICAL JOINT STOCK COMPAN | VIETNAM | $1.0M | 20 | $50.0K |
| 18 | NORDIC PHARMACEUTICAL COMPANY SAC | PERU | $850.0K | 17 | $50.0K |
| 11 | EVERSANA EVERSANA ★ | UNITED STATES | $650.0K | 13 | $50.0K |
| 16 | EUGIA US LLC | UNITED STATES | $600.0K | 12 | $50.0K |
| 13 | OOOJODAS EXPOIM | RUSSIA | $500.0K | 10 | $50.0K |
EVERSANA EVERSANA ranks #11 among 751 Syringe importers from India. Average shipment value of $50.0K compared to the market average of $57.6K. The closest competitors by value are DUC MINH MEDICAL JOINT STOCK COMPAN and NORDIC PHARMACEUTICAL COMPANY SAC.
Where Does EVERSANA EVERSANA Import Syringe To?
Destination countries from 13 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $589.0K | 13 | 100.0% |
EVERSANA EVERSANA imports Syringe to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $589.0K.
What Syringe Formulations Does EVERSANA EVERSANA Import?
| Formulation | Value | Shipments |
|---|---|---|
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 80MG IN 0.8ML PREFILLED SYRINGE | $127.4K | 3 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 30MG IN 0.3ML PREFILLED SYRINGE | $100.0K | 2 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP 60MG IN 0.6ML PREFILLED SYRINGE | $100.0K | 2 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP 40MG IN 0.4ML PREFILLED SYRINGE | $61.6K | 2 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARIN SODIUM INJECTION USP, 100MG PRE-FILLEDSYRINGES | $50.0K | 1 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 40MG IN 0.4ML PREFILLED SYRINGE | $50.0K | 1 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARIN SODIUM INJECTION USP, 120MG PRE-FILLEDSYRINGES | $50.0K | 1 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP 150MG PRE FILLED SYRINGES | $50.0K | 1 |
EVERSANA EVERSANA imports 8 distinct Syringe formulations from India. The top formulation is LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, with 3 shipments worth $127.4K.
Regulatory Requirements: Importing Syringe into United States
What EVERSANA EVERSANA and other importers must comply with to import Syringe from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Syringe
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Syringe from India and How Much Does EVERSANA EVERSANA Import?
India exported $43.3M worth of Syringe through 3,522 shipments from 291 suppliers to 154 countries, serving 751 buyers globally. EVERSANA EVERSANA imports $589.0K of this total, accounting for 0.4% of India's Syringe exports with 13 shipments from UNITED STATES. This is verified from 13 customs shipment records covering 8 distinct formulations.
What Is the Average Order Value for EVERSANA EVERSANA's Syringe Imports?
EVERSANA EVERSANA's average Syringe order value is $45.3K per consignment, based on 13 shipments totaling $589.0K. EVERSANA EVERSANA is based in UNITED STATES and ranks #11 among all Syringe importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Syringe to EVERSANA EVERSANA?
EVERSANA EVERSANA sources Syringe from 1 verified Indian supplier: GLAND PHARMA LIMITED ($589.0K, 100.0%). This is based on 13 customs records.
How Does EVERSANA EVERSANA Compare to Other Syringe Importers?
EVERSANA EVERSANA ranks #11 among 751 Syringe importers from India with a 0.4% market share. The top 3 importers are FRESENIUS KABI USA, LLC ($17.1M), YUSEN LOGISTICS BENELUX BELGIUM ($4.8M), BOSTON ONCOLOGY ARABIA ($4.8M). EVERSANA EVERSANA processed 13 shipments from UNITED STATES.
About EVERSANA EVERSANA
EVERSANA EVERSANA imports 5 products worth $5.6M. Beyond Syringe, top products include Heparin, Ketorolac, Vancomycin, Enoxaparin. View the complete EVERSANA EVERSANA profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Syringe — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Syringe shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: EVERSANA EVERSANA matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as EVERSANA EVERSANA's capped import value divided by total capped export value for Syringe across all Indian exporters.
- 5.Verified Records: This page is backed by 13 individual customs records matching EVERSANA EVERSANA importing Syringe, covering 8 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 154+ countries, 751+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Syringe Import Data for EVERSANA EVERSANA
Access order-level details, pricing data, supplier connections, and competitive analysis for EVERSANA EVERSANA's Syringe imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
EVERSANA EVERSANA
Full Company Profile →
5 products · $5.6M total trade · 4 categories
EVERSANA EVERSANA × Syringe
Verified from customs records
Company Overview
Top Products by EVERSANA EVERSANA
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for EVERSANA EVERSANA.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Syringe. For current order-level data, contact TransData Nexus.